Related references
Note: Only part of the references are listed.Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients
Ken Ogasawara et al.
CLINICAL PHARMACOKINETICS (2013)
Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients
Nayoung Han et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetics of tacrolimus in kidney transplant patients
R. Velickovic-Radovanovic et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
Xiao-cong Zuo et al.
PHARMACOGENETICS AND GENOMICS (2013)
Population Pharmacokinetic Modelling and Design of a Bayesian Estimator for Therapeutic Drug Monitoring of Tacrolimus in Lung Transplantation
Caroline Monchaud et al.
CLINICAL PHARMACOKINETICS (2012)
In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
H. de Jonge et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation
Flora Tshinanu Musuamba et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
Michael N. Neely et al.
THERAPEUTIC DRUG MONITORING (2012)
Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week
Katherine A. Barraclough et al.
TRANSPLANT INTERNATIONAL (2012)
Dosing equation for tacrolimus using genetic variants and clinical factors
Chaitali Passey et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®
Jean-Baptiste Woillard et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis
X. -J. Shi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
Karsten Midtvedt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients
Laure Elens et al.
PHARMACOGENOMICS (2011)
Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2010)
A Prospective, Open-Label, Observational Clinical Cohort Study of the Association Between Delayed Renal Allograft Function, Tacrolimus Exposure, and CYP3A5 Genotype in Adult Recipients
Dirk R. J. Kuypers et al.
CLINICAL THERAPEUTICS (2010)
Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The 'ReSpECT' Study
J. M. Neuberger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2009)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients
Rogier R. Press et al.
THERAPEUTIC DRUG MONITORING (2009)
Rimonabant Affects Cyclosporine A, but Not Tacrolimus Pharmacokinetics in Renal Transplant Recipients
Rune Amundsen et al.
TRANSPLANTATION (2009)
A Randomized Trial Comparing Renal Function in Older Kidney Transplant Patients Following Delayed Versus Immediate Tacrolimus Administration
Amado Andres et al.
TRANSPLANTATION (2009)
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
Dennis A. Hesselink et al.
PHARMACOGENETICS AND GENOMICS (2008)
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
Pal Falck et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients
D. Li et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Apparent low absorbers of cyclosporine microemulsion have higher requirements for tacrolimus in renal transplantation
Andrew A. House et al.
CLINICAL TRANSPLANTATION (2007)
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
Michel Mourad et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro
Y Dai et al.
DRUG METABOLISM AND DISPOSITION (2006)
Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus
LK Kamdem et al.
CLINICAL CHEMISTRY (2005)
Cytochrome p450 3A4 and p-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea
W Lemahieu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Two doses of Daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age
A Osuna et al.
TRANSPLANTATION PROCEEDINGS (2005)
Quantification of lean bodyweight
S Janmahasatian et al.
CLINICAL PHARMACOKINETICS (2005)
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation
IAM MacPhee et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels
DA Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
CE Staatz et al.
CLINICAL PHARMACOKINETICS (2004)
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients
CE Staatz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
